Imeglimin - CAS# 775351-65-0 Catalog No.:M10356-2 Indiplon in the treatment of

Indiplon in the treatment of sleep disorders

Quizartinib (AC220) is a novel compound expressly optimized as a FLT3 inhibitor for the treatment of acute myeloid leukemia (AML)

Smiles: CN1C(=O)N(CCCCN2CCN(CC2)C2N=CC=CN=2)N=CC1=O

5 μM for FLK-1 (VEGFR-2) and HER2

Molecular Weight: 554

Imeglimin - CAS# 775351-65-0 Catalog No.:M10356-2 Indiplon in the treatment ofImeglimin is an oxidative phosphorylation blocker that acts to inhibit hepatic gluconeogenesis, increase muscle glucose uptake, and restore normal insulin secretion. Imeglimin is being developed as an oral anti diabetic. Various research protocols are being known through various scientists. Early studies showed that imeglimin is as effective as metformin in regulating glycaemic control. (last updated : 2 19 2016). Product information CAS Number: